Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1

Conditions

Lung Neoplasms 6 Pleural Effusion 4 Pleural Effusion, Malignant 3 Carcinoma, Non-Small-Cell Lung 3 Mesothelioma 2 Solitary Pulmonary Nodule 1 Respiratory Tract Infections 1 Pleural Diseases 1 Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Mediastinal Neoplasms 1 Lung Diseases, Interstitial 1 Liver Neoplasms 1 Gastrointestinal Neoplasms 1 Disease 1

Interventions

pembrolizumab 61 Carboplatin 44 Pemetrexed 31 Paclitaxel 31 Docetaxel 31 Cisplatin 27 Gemcitabine 24 Nivolumab 23 Erlotinib Hydrochloride 21 Bevacizumab 18 Ipilimumab 11 osimertinib 10 Drug Therapy 10 atezolizumab 9 Radiosurgery 9 Cyclophosphamide 9 Cetuximab 9 Blood Specimen Collection 9 durvalumab 8 cemiplimab 8 Radiotherapy 8 budigalimab 7 Fluorouracil 7 Dexamethasone 7 trametinib 6 fludarabine 6 dostarlimab 6 avelumab 6 Taxes 6 130-nm albumin-bound paclitaxel 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Thoracoscopy × Thoracic × Clear all

NCT04793607 2021-03-11

IMPE-F

Northumbria Healthcare NHS Foundation Trust

Neoplasms, Pleural Effusion, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡